Yves Ozier

The influence of timing of administration on the analgesic efficacy of parecoxib in orthopedic surgery. (2008)

Martinez, Valéria, Belbachir, Anissa, Jaber, Aithem, Cherif, Kamel, Jamal, Adel, Ozier, Yves, ...

BACKGROUND: Parecoxib, a selective cyclooxygenase-2 inhibitor, may reduce postoperative pain without increasing bleeding when administered before surgery. METHODS: We randomly assigned 62 patients...

The influence of timing of administration on the analgesic efficacy of parecoxib in orthopedic surgery. (2008)

Martinez, Valéria, Belbachir, Anissa, Jaber, Aithem, Cherif, Kamel, Jamal, Adel, Ozier, Yves, ...

BACKGROUND: Parecoxib, a selective cyclooxygenase-2 inhibitor, may reduce postoperative pain without increasing bleeding when administered before surgery. METHODS: We randomly assigned 62 patients...

Management of bleeding following major trauma: a European guideline (2007)

Spahn, Donat R, Cerny, Vladimir, Coats, Timothy J, Duranteau, Jacques, Fernández-Mondéjar, Enrique, Gordini, Giovanni, ...

Abstract Introduction Evidence-based recommendations can be made with respect to many aspects of the acute management of the bleeding trauma patient, which when implemented may lead to improved...

Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective (2006)

Vincent, Jean-Louis, Rossaint, Rolf, Riou, Bruno, Ozier, Yves, Zideman, David, Spahn, Donat R

Abstract Introduction Our aim was to develop consensus guidelines for use of recombinant activated factor VII (rFVIIa) in massive hemorrhage. Methods A guidelines committee derived the...